Legacy Pharmaceutical And Chemical Businesses Will Decline As Regulations Tighten
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 17 Analysts
Published
04 Jun 25
Updated
09 Aug 25
AnalystLowTarget's Fair Value
€105.50
6.3% overvalued intrinsic discount09 Aug
€112.15
1Y
-34.6%7D
0.09%